These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 7987657
1. Factors determining the long-term outcome of surgery for acromegaly. Osman IA, James RA, Chatterjee S, Mathias D, Kendall-Taylor P. QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657 [Abstract] [Full Text] [Related]
2. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S, Grossman AB, Besser GM, Wass JA. Clin Endocrinol (Oxf); 1996 Oct; 45(4):407-13. PubMed ID: 8959078 [Abstract] [Full Text] [Related]
3. Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly. Biermasz NR, Smit JW, van Dulken H, Roelfsema F. Clin Endocrinol (Oxf); 2002 Mar; 56(3):313-9. PubMed ID: 11940042 [Abstract] [Full Text] [Related]
4. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma. Lissett CA, Peacey SR, Laing I, Tetlow L, Davis JR, Shalet SM. Clin Endocrinol (Oxf); 1998 Nov; 49(5):653-7. PubMed ID: 10197082 [Abstract] [Full Text] [Related]
6. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. Kaltsas GA, Isidori AM, Florakis D, Trainer PJ, Camacho-Hubner C, Afshar F, Sabin I, Jenkins JP, Chew SL, Monson JP, Besser GM, Grossman AB. J Clin Endocrinol Metab; 2001 Apr; 86(4):1645-52. PubMed ID: 11297598 [Abstract] [Full Text] [Related]
8. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study. Plöckinger U, Quabbe HJ. Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331 [Abstract] [Full Text] [Related]
9. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission. De P, Rees DA, Davies N, John R, Neal J, Mills RG, Vafidis J, Davies JS, Scanlon MF. J Clin Endocrinol Metab; 2003 Aug; 88(8):3567-72. PubMed ID: 12915637 [Abstract] [Full Text] [Related]
10. Evaluation of surgery for acromegaly: role of intraoperative growth hormone measurement? Valdemarsson S, Ljunggren S, Cervin A, Svensson C, Isaksson A, Nordström CH, Siesjö P. Scand J Clin Lab Invest; 2001 Aug; 61(6):459-70. PubMed ID: 11681536 [Abstract] [Full Text] [Related]
11. Early postoperative basal serum GH level and the GH response to TRH in relation to the long-term outcome of surgical treatment for acromegaly: a report on 39 patients. Valdemarsson S, Bramnert M, Cronquist S, Elner A, Eneroth CM, Hedner P, Lindvall-Axelsson M, Nordström CH, Strömblad LG. J Intern Med; 1991 Jul; 230(1):49-54. PubMed ID: 1906090 [Abstract] [Full Text] [Related]